Research
Novel anti-platelet agent engineered by Australian researchers
Australian and US researchers have genetically engineered a novel antithrombotic drug, which binds only to activated platelets at the site of a thrombus.
By only binding to activated platelets, not sealing platelets, there is no risk of bleeding complications with the...
Australian and US researchers have genetically engineered a novel antithrombotic drug, which binds only to activated platelets at the site...